| Resveratrol |
NCT04258306 |
Completed |
Not Applicable |
Pilot Study to Evaluate the Plasma Profile of Revifast |
Nutrient; Excess|Product Use Issue |
https://ClinicalTrials.gov/show/NCT04258306 |
| Resveratrol |
NCT03933163 |
Recruiting |
Phase 2 |
Micronised Resveratrol as a Treatment for Friedreich Ataxia |
Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT03933163 |
| Resveratrol |
NCT03525379 |
Recruiting |
Phase 2 |
Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure |
Congestive Heart Failure Chronic |
https://ClinicalTrials.gov/show/NCT03525379 |
| Resveratrol |
NCT04314739 |
Completed |
Not Applicable |
The Effects of Resveratrol Supplementation on Inflammation and Cognitive Performance in Healthy Adults |
Cognitive Change|Mood|Systemic Inflammation |
https://ClinicalTrials.gov/show/NCT04314739 |
| Resveratrol |
NCT03762096 |
Recruiting |
Not Applicable |
Short Interval Resveratrol Trial in Cardiovascular Surgery |
Diabetes Mellitus, Type 2|Coronary Artery Disease |
https://ClinicalTrials.gov/show/NCT03762096 |
| Resveratrol |
NCT02565979 |
Completed |
Not Applicable |
Long-term Resveratrol and Metabolism |
Pre-diabetes |
https://ClinicalTrials.gov/show/NCT02565979 |
| Resveratrol |
NCT03665740 |
Recruiting |
Phase 2 |
Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER) |
Gulf War Illness |
https://ClinicalTrials.gov/show/NCT03665740 |
| Resveratrol |
NCT02245932 |
Completed |
Not Applicable |
Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial) |
Pulmonary Disease, Chronic Obstructive |
https://ClinicalTrials.gov/show/NCT02245932 |
| Resveratrol |
NCT03448094 |
Completed |
Not Applicable |
The Effects of Resveratrol Supplementation on Cognition, Cerebral Blood Flow, Microbiota and Systemic Inflammation. |
Cognitive Function and Mood|Cerebral Blood Flow|Systemic Inflammation|Gut Microbiota|Overweight and Obesity |
https://ClinicalTrials.gov/show/NCT03448094 |
| Resveratrol |
NCT03253913 |
Recruiting |
Phase 2 |
Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial |
Lymphangioleiomyomatosis |
https://ClinicalTrials.gov/show/NCT03253913 |
| Resveratrol |
NCT03446625 |
Completed |
Phase 3 |
Resveratrol as a Preventive Treatment of OHSS |
Infertility |
https://ClinicalTrials.gov/show/NCT03446625 |
| Resveratrol |
NCT01677611 |
Completed |
Phase 1 |
Effects of Resveratrol in Patients With Type 2 Diabetes |
Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT01677611 |
| Resveratrol |
NCT02321176 |
Unknown status |
Not Applicable |
Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood |
Eye Disease |
https://ClinicalTrials.gov/show/NCT02321176 |
| Resveratrol |
NCT03743636 |
Recruiting |
Phase 3 |
Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease |
Peripheral Artery Disease |
https://ClinicalTrials.gov/show/NCT03743636 |
| Resveratrol |
NCT02475564 |
Completed |
Phase 4 |
Resveratrol for Pain Due to Endometriosis |
Endometriosis |
https://ClinicalTrials.gov/show/NCT02475564 |
| Resveratrol |
NCT01782911 |
Completed |
Not Applicable |
Effect of Resveratrol on Metabolic Parameters and Oocyte Quality in PCOS Patients |
Androgen Profile|Inflammatory Markers|IVF Outcome |
https://ClinicalTrials.gov/show/NCT01782911 |
| Resveratrol |
NCT02621554 |
Completed |
Not Applicable |
Impact of Resveratrol on Brain Function and Structure |
Healthy |
https://ClinicalTrials.gov/show/NCT02621554 |
| Resveratrol |
NCT01451918 |
Completed |
Phase 2 |
Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol |
Dyslipidaemia|Insulin Resistance |
https://ClinicalTrials.gov/show/NCT01451918 |
| Resveratrol |
NCT01476592 |
Completed |
Not Applicable |
A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors |
Neuroendocrine Tumor |
https://ClinicalTrials.gov/show/NCT01476592 |
| Resveratrol |
NCT02244879 |
Completed |
Phase 3 |
Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients |
Type 2 Diabetes Mellitus|Inflammation|Insulin Resistance|Other Disorders of Bone Density and Structure |
https://ClinicalTrials.gov/show/NCT02244879 |
| Resveratrol |
NCT02549924 |
Terminated |
Phase 2 |
Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus |
Type 2 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT02549924 |
| Resveratrol |
NCT02129595 |
Completed |
Not Applicable |
Resveratrol and First-degree Relatives of Type 2 Diabetic Patients |
Pre-diabetes |
https://ClinicalTrials.gov/show/NCT02129595 |
| Resveratrol |
NCT02247596 |
Completed |
Phase 2 |
Effects of High-Dose Resveratrol in Non-Diabetic Obese Males |
Obesity|Diabetes |
https://ClinicalTrials.gov/show/NCT02247596 |
| Resveratrol |
NCT02433925 |
Completed |
Phase 3 |
Resveratrol's Effects on Inflammation and Oxidative Stress in Chronic Kidney Disease |
Chronic Renal Insufficiency |
https://ClinicalTrials.gov/show/NCT02433925 |
| Resveratrol |
NCT01339884 |
Completed |
Phase 1|Phase 2 |
A Study of Resveratrol as Treatment for Friedreich Ataxia |
Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT01339884 |
| Resveratrol |
NCT02625376 |
Unknown status |
Not Applicable |
Resveratrol for Exudative Age-Related Macular Degeneration |
AMD|Age-related Macular Degeneration|Choroidal Neovascularisation |
https://ClinicalTrials.gov/show/NCT02625376 |
| Resveratrol |
NCT01638780 |
Unknown status |
Not Applicable |
Resveratrol and Type 2 Diabetes |
Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT01638780 |
| Resveratrol |
NCT01364961 |
Completed |
Not Applicable |
Resveratrol and Serum Apo A-I |
Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01364961 |
| Resveratrol |
NCT02246660 |
Completed |
Not Applicable |
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial) |
Peripheral Arterial Disease |
https://ClinicalTrials.gov/show/NCT02246660 |
| Resveratrol |
NCT02415114 |
Completed |
Phase 1 |
An Open Label Study Evaluating the Effectiveness of Omega Q Plus® Resveratrol at Increasing Blood Levels of CoQ10 |
CoQ10 Blood Levels|CoQ10 Blood Levels With Statin Use |
https://ClinicalTrials.gov/show/NCT02415114 |
| Resveratrol |
NCT02114892 |
Completed |
Phase 2 |
Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion |
Metabolic Syndrome X |
https://ClinicalTrials.gov/show/NCT02114892 |
| Resveratrol |
NCT01997762 |
Unknown status |
Phase 4 |
Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes? |
Gestational Diabetes |
https://ClinicalTrials.gov/show/NCT01997762 |
| Resveratrol |
NCT01914081 |
Recruiting |
Phase 3 |
Resveratrol: A Potential Anti- Remodeling Agent in Heart Failure, From Bench to Bedside |
Dilated Cardiomyopathy |
https://ClinicalTrials.gov/show/NCT01914081 |
| Resveratrol |
NCT01492114 |
Completed |
Phase 3 |
Anti-inflammatory and Antioxidant Effects of Resveratrol on Healthy Adults. |
Chronic Subclinic Inflammation|Redox Status |
https://ClinicalTrials.gov/show/NCT01492114 |
| Resveratrol |
NCT01173640 |
Completed |
Not Applicable |
Resveratrol and Midazolam Metabolism |
Healthy |
https://ClinicalTrials.gov/show/NCT01173640 |
| Resveratrol |
NCT03866200 |
Recruiting |
Phase 2 |
Resveratrol Trial for Relief of Pain in Pseudoachondroplasia |
Pseudoachondroplasia |
https://ClinicalTrials.gov/show/NCT03866200 |
| Resveratrol |
NCT01038089 |
Completed |
Not Applicable |
Pilot Study Of The Effects Of Resveratrol On Endothelial Function In Subjects With Type 2 Diabetes Mellitus |
Type 2 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT01038089 |
| Resveratrol |
NCT03728777 |
Completed |
Not Applicable |
Resveratrol Supplementation in Patients With Mitochondrial Myopathies and Skeletal Muscle Fatty Acid Oxidation Disorders |
Mitochondrial Myopathies|Fatty Acid Oxidation Defects |
https://ClinicalTrials.gov/show/NCT03728777 |
| Resveratrol |
NCT02905799 |
Recruiting |
Phase 3 |
Resveratrol in Knee Osteoarthritis |
Knee Osteoarthritis |
https://ClinicalTrials.gov/show/NCT02905799 |
| Resveratrol |
NCT02030977 |
Completed |
Phase 2|Phase 3 |
The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis |
Non Alcoholic Fatty Liver |
https://ClinicalTrials.gov/show/NCT02030977 |
| Resveratrol |
NCT01464801 |
Completed |
Not Applicable |
Resveratrol in Patients With Non-alcoholic Fatty Liver Disease |
Fatty Liver |
https://ClinicalTrials.gov/show/NCT01464801 |
| Resveratrol |
NCT01412645 |
Completed |
Not Applicable |
Long-term Investigation of Resveratrol in Obesity |
Obesity|Inflammation|Insulin Sensitivity|Osteoporosis |
https://ClinicalTrials.gov/show/NCT01412645 |
| Resveratrol |
NCT01375959 |
Unknown status |
Not Applicable |
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance |
Impaired Glucose Tolerance |
https://ClinicalTrials.gov/show/NCT01375959 |
| Resveratrol |
NCT03597568 |
Recruiting |
Not Applicable |
Resveratrol and Vascular Function in CKD |
Chronic Kidney Diseases|Endothelial Dysfunction |
https://ClinicalTrials.gov/show/NCT03597568 |
| Resveratrol |
NCT01564381 |
Completed |
Phase 1|Phase 2 |
Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women |
Cardiovascular Disease |
https://ClinicalTrials.gov/show/NCT01564381 |
| Resveratrol |
NCT02261844 |
Withdrawn |
Phase 1|Phase 2 |
Resveratrol and Human Hepatocyte Function in Cancer |
Liver Cancer |
https://ClinicalTrials.gov/show/NCT02261844 |
| Resveratrol |
NCT01720459 |
Unknown status |
Not Applicable |
Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients |
Polycystic Ovary Syndrome (PCOS) |
https://ClinicalTrials.gov/show/NCT01720459 |
| Resveratrol |
NCT01747252 |
Completed |
Not Applicable |
Pharmacokinetics of Resveratrol Comprising Products |
Healthy |
https://ClinicalTrials.gov/show/NCT01747252 |
| Resveratrol |
NCT02616822 |
Completed |
Phase 1 |
Effects of Trans-Resveratrol in Endothelial Function in Hypertensive Patients |
Endothelial Dysfunction |
https://ClinicalTrials.gov/show/NCT02616822 |
| Resveratrol |
NCT01158417 |
Unknown status |
Phase 2|Phase 3 |
Resveratrol in Type2 Diabetes and Obesity |
Type 2 Diabetes|Obesity|Insulin Resistance |
https://ClinicalTrials.gov/show/NCT01158417 |
